Jean‐Paul Molens

1.3k total citations
20 papers, 1.1k citations indexed

About

Jean‐Paul Molens is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jean‐Paul Molens has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 10 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Jean‐Paul Molens's work include Immunotherapy and Immune Responses (18 papers), Immune Cell Function and Interaction (13 papers) and CAR-T cell therapy research (9 papers). Jean‐Paul Molens is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Immune Cell Function and Interaction (13 papers) and CAR-T cell therapy research (9 papers). Jean‐Paul Molens collaborates with scholars based in France, United States and United Kingdom. Jean‐Paul Molens's co-authors include Joël Plumas, Laurence Chaperot, Olivier Manches, Gabrielle Lui, Jean‐Claude Bensa, Jean‐Jacques Sotto, Marie‐Christine Jacob, Rémy Gressin, Dominique Leroux and J. J. Sotto and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jean‐Paul Molens

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Paul Molens France 13 751 305 206 195 183 20 1.1k
Christiane Guret United States 12 663 0.9× 139 0.5× 234 1.1× 133 0.7× 141 0.8× 15 1.0k
Eleanor L. Marshall United States 5 497 0.7× 145 0.5× 304 1.5× 236 1.2× 116 0.6× 5 841
Kandasamy Hariharan United States 17 467 0.6× 292 1.0× 286 1.4× 348 1.8× 353 1.9× 36 1.1k
Sonja Meixlsperger Germany 11 595 0.8× 293 1.0× 228 1.1× 67 0.3× 132 0.7× 14 918
G. Reisbach Germany 16 458 0.6× 511 1.7× 258 1.3× 123 0.6× 174 1.0× 26 1.1k
Sam Litwin United States 12 514 0.7× 180 0.6× 208 1.0× 244 1.3× 62 0.3× 26 945
Sambasiva P. Rao United States 12 803 1.1× 122 0.4× 195 0.9× 188 1.0× 116 0.6× 21 1.1k
Nadja Prang Germany 17 448 0.6× 837 2.7× 269 1.3× 376 1.9× 234 1.3× 23 1.2k
Kathleen F. Bongiovanni United States 8 1.1k 1.4× 311 1.0× 195 0.9× 185 0.9× 314 1.7× 10 1.4k
H. Bernhard Germany 19 876 1.2× 669 2.2× 459 2.2× 255 1.3× 96 0.5× 35 1.5k

Countries citing papers authored by Jean‐Paul Molens

Since Specialization
Citations

This map shows the geographic impact of Jean‐Paul Molens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Paul Molens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Paul Molens more than expected).

Fields of papers citing papers by Jean‐Paul Molens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Paul Molens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Paul Molens. The network helps show where Jean‐Paul Molens may publish in the future.

Co-authorship network of co-authors of Jean‐Paul Molens

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Paul Molens. A scholar is included among the top collaborators of Jean‐Paul Molens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Paul Molens. Jean‐Paul Molens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mouret, Stéphane, Jean‐Paul Molens, Marc Manceau, et al.. (2024). Circulating immune landscape in melanoma patients undergoing anti-PD1 therapy reveals key immune features according to clinical response to treatment. Frontiers in Immunology. 15. 1507938–1507938. 1 indexed citations
2.
Walencik, Alexandre, Karine Laulagnier, Jean‐Paul Molens, et al.. (2021). Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells. Vaccines. 9(2). 141–141. 6 indexed citations
3.
Aspord, Caroline, Corinne Leloup, Jean‐Paul Molens, et al.. (2014). Imiquimod Inhibits Melanoma Development by Promoting pDC Cytotoxic Functions and Impeding Tumor Vascularization. Journal of Investigative Dermatology. 134(10). 2551–2561. 60 indexed citations
4.
Hannani, Dalil, Françoise Gabert, David Laurin, et al.. (2010). Photochemotherapy Induces the Apoptosis of Monocytes Without Impairing Their Function. Transplantation. 89(5). 492–499. 25 indexed citations
5.
6.
Lui, Gabrielle, et al.. (2009). Plasmacytoid Dendritic Cells Capture and Cross-Present Viral Antigens from Influenza-Virus Exposed Cells. PLoS ONE. 4(9). e7111–e7111. 77 indexed citations
7.
Chaperot, Laurence, Jean‐Paul Molens, Paulette Mezin, et al.. (2007). Virosome-mediated delivery of tumor antigen to plasmacytoid dendritic cells. Vaccine. 25(19). 3913–3921. 31 indexed citations
8.
Chaperot, Laurence, et al.. (2006). Virus or TLR Agonists Induce TRAIL-Mediated Cytotoxic Activity of Plasmacytoid Dendritic Cells. The Journal of Immunology. 176(1). 248–255. 206 indexed citations
9.
Chaperot, Laurence, et al.. (2006). Mechanisms of TRAIL-induced apoptosis in leukemic plasmacytoid dendritic cells. Experimental Hematology. 34(12). 1655–1662. 16 indexed citations
10.
Manches, Olivier, Joël Plumas, Gabrielle Lui, et al.. (2005). Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.. PubMed. 90(5). 625–34. 29 indexed citations
11.
Lui, Gabrielle, Olivier Manches, Laurence Chaperot, et al.. (2004). Preparation of purified lymphoma cells suitable for therapy. Cytotherapy. 6(3). 235–243. 8 indexed citations
12.
Molens, Jean‐Paul, et al.. (2004). Impairment of death‐inducing signalling complex formation in CD95‐resistant human primary lymphoma B cells. British Journal of Haematology. 124(6). 746–753. 12 indexed citations
13.
Manches, Olivier, Gabrielle Lui, Laurence Chaperot, et al.. (2003). In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas. Blood. 101(3). 949–954. 288 indexed citations
14.
Chaperot, Laurence, Olivier Manches, Agnès Moine, et al.. (2002). Differentiation of anti‐tumour cytotoxic T lymphocytes from autologous peripheral blood lymphocytes in non‐Hodgkin's lymphomas. British Journal of Haematology. 119(2). 425–431. 9 indexed citations
15.
Chaperot, Laurence, Marie‐Christine Jacob, Jean‐Paul Molens, et al.. (2000). From the Study of Tumor Cell Immunogenicity to the Generation of Antitumor Cytotoxic Cells in Non-Hodgkin's Lymphomas. Leukemia & lymphoma. 38(3-4). 247–263. 6 indexed citations
16.
Chaperot, Laurence, Joël Plumas, Marie‐Christine Jacob, et al.. (1999). Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin’s lymphomas. Experimental Hematology. 27(3). 479–488. 41 indexed citations
17.
Chaperot, Laurence, Marie‐Hélène Delfau‐Larue, Marie‐Christine Jacob, et al.. (1999). Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin’s lymphomas. Experimental Hematology. 27(7). 1185–1193. 12 indexed citations
18.
Plumas, Joël, Marie‐Christine Jacob, Laurence Chaperot, et al.. (1998). Tumor B Cells From Non-Hodgkin's Lymphoma Are Resistant to CD95 (Fas/Apo-1)–Mediated Apoptosis. Blood. 91(8). 2875–2885. 100 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christiane Guret Breakdown of academic impact, for papers by Eleanor L. Marshall Breakdown of academic impact, for papers by Kandasamy Hariharan Breakdown of academic impact, for papers by Sonja Meixlsperger Breakdown of academic impact, for papers by G. Reisbach Breakdown of academic impact, for papers by Sam Litwin Breakdown of academic impact, for papers by Sambasiva P. Rao Breakdown of academic impact, for papers by Nadja Prang Breakdown of academic impact, for papers by Kathleen F. Bongiovanni Breakdown of academic impact, for papers by H. Bernhard
Rankless by CCL
2026